Howard W. Robin
2019
In 2019, Howard W. Robin earned a total compensation of $9.9M as President and Chief Executive Officer at Nektar Therapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Option Awards | $4,652,065 |
|---|---|
| Salary | $1,017,400 |
| Stock Awards | $4,100,860 |
| Other | $168,925 |
| Total | $9,939,250 |
Robin received $4.7M in option awards, accounting for 47% of the total pay in 2019.
Robin also received $1M in salary, $4.1M in stock awards and $168.9K in other compensation.
Rankings
In 2019, Howard W. Robin's compensation ranked 755th out of 13,971 executives tracked by ExecPay. In other words, Robin earned more than 94.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 755 out of 13,971 | 95th |
Division Manufacturing | 268 out of 5,692 | 95th |
Major group Chemicals And Allied Products | 72 out of 2,189 | 97th |
Industry group Drugs | 60 out of 1,875 | 97th |
Industry Pharmaceutical Preparations | 49 out of 1,387 | 97th |
Source: SEC filing on April 30, 2021.
Robin's colleagues
We found three more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2019.